American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
ENDRA Life Sciences Inc.
$7.8MMarket cap
$0Revenue · FY2020
-$7.0MNet income
11Employees
NDRANASDAQ
2017IPO
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2020
- $0
- Net income
- -$7.0M
- Total assets
- $3.9M
- Market cap
- $7.8M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $7.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 28, 2017
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review ENDRA Life Sciences Inc..
Write a review
Explore
Browse all →
